CASI Pharmaceuticals
CASI
CASI
85 hedge funds and large institutions have $127M invested in CASI Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.45% more ownership
Funds ownership: 3.34% → 3.8% (+0.45%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
85
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.56M | |
| 2 | +$7.11M | |
| 3 | +$3.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.18M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.56M |
Top Sellers
| 1 | -$287K | |
| 2 | -$133K | |
| 3 | -$125K | |
| 4 |
Millennium Management
New York
|
-$106K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$85.5K |